Price Alert

Checkmate Pharmaceuticals... (CMPI)

NASDAQ: CMPI · Real-Time Price · USD

10.50

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

Checkmate Pharmaceuticals Revenue

Checkmate Pharmaceuticals reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2022, Checkmate Pharmaceuticals generated $0 in revenue.

Revenue (ttm)

Revenue Growth

n/a

Price / Sales Ratio

Revenue / Employee

Employees

Market Cap

Revenue Chart

Revenue History

Fiscal Year End	Revenue	% Change
Dec 31, 2021	0	n/a
Dec 31, 2020	0	n/a
Dec 31, 2019	0	n/a
Dec 31, 2018	0	n/a

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.